ADH1A and ovarian carcinoma: Significantly increased expression of ADH1A in ovarian cancer tissue, with disproportionately unincreased levels of aldehyde dehydrogenase (degradation enzyme), may lead to the increased production of acetaldehyde and the support of carcinogenesis in ovarian tissue [45].